WFA
TAK icon

Wipfli Financial Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Wipfli Financial Advisors’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$72K Buy
+5,551
New +$77.2K 0.01% 901

Other funds holding TAK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wipfli Financial Advisors's TAK Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Takeda Pharmaceutical (TAK) in Q3 2022: 5,551 shares worth $72K. The stake represents 0.01% of the portfolio and ranks #901 among its holdings.

276 funds tracked by Wall St. Rank hold TAK as of Q3 2022.

  • Wipfli Financial Advisors held 5,551 shares of Takeda Pharmaceutical worth $72K as of Q3 2022.
  • Takeda Pharmaceutical was a new Wipfli Financial Advisors position in Q3 2022.
  • Takeda Pharmaceutical made up 0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #901 holding.
  • 276 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.